Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-12-16
1994-04-12
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514561, 514625, 514629, 514866, A61K 3142, A61K 31195, A61K 3116
Patent
active
053026098
ABSTRACT:
The present invention is a novel method for the treatment of renal hypertrophy and hyperplasia associated with diabetic nephropathy. The method of the present invention generally comprises the administration to the diabetic patient of a compound which inhibits glycosphingolipid synthesis, more particularly, an inhibitor of GlcCer synthase or 3-ketodihydrosphingosine synthase.
REFERENCES:
patent: 3573925 (1971-04-01), Harned
patent: 5041441 (1991-08-01), Radin et al.
patent: 5061721 (1991-10-01), Cordi et al.
Shukla, G. S. et al., "Rapid Kidney Changes Resulting from Glycosphingolipid Depletion by Treatment with a Glucosyltransferase Inhibitor", Bioch. Biophys. Acta, 1083:101-108 (1991).
Brownlee, M., "Glycosylation Products as Toxic Mediators of Diabetic Complications", Annu. Rev. Med., 42:159-166 (1991).
Holleran, W. M. et al., "Sphingolipids Are Required for Mammalian Epidermal Barrier Function", J. Clin. Invest., 88:1338-1345 (1991).
Shukla, A. et al., "Metabolism of D-[.sup.3 H]threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, An Inhibitor of Glucosylceramide Synthesis, and the Synergistic Action of an Inhibitor of Microsomal Monooxygenase", J. Lipid Res., 32:713-722 (1991).
Shayman, J. A. et al., "Glucosphingolipid Dependence of Hormone-stimulated Inositol Trisphosphate Formation", J. Biol. Chem., 265:12135-12138 (1990).
Craven, P. A. et al., "Increase in Diacylglycerol Mass in Isolated Glomeruli by Glucose from De Novo Synthesis of Glycerolipids", Diabetes, 39:667-674 (1990).
Shukla, G. S. et al., "Glucosylceramide Synthase of Mouse Kidney: Further Characterization with an Improved Assay Method", Arch. Biochem. Biophys., 283:372-378 (1990).
Medlock, K. A. et al., "Inhibition of Serine Palmitoyltransferase in Vitro and Long-Chain Base Biosynthesis in Intact Chinese Hamster Ovary Cells by .beta.-Chloroalanine", Biochem., 27:7079-7084 (1988).
Radin, N. S. et al., "Glucosphingolipids as Sites of Action in the Chemotherapy of Cancer", Biochem. Pharmacol., 37:2879-2886 (1988).
Inokuchi, J. et al., "Preparation of the Active Isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, Inhibitor of Murine Glucocerebroside Synthetase", J. Lipid Res., 28:565-571 (1987).
Coste, H. et al., "Topology of Glucosylceramide Synthesis in Golgi Membranes from Porcine Submaxillary Glands", Biochem. Biophys. Acta, 858:6-12 (1986).
Beyer-Mears, A. et al., "Glomerular Polyol Accumulation in Diabetes and its Prevention by Oral Sorbinil", Diabetes, 33:604-607 (1984).
Spiro, M. J., "Effect of Diabetes on the Sugar Nucleotides in Several Tissues of the Rat", Diabetologia, 26:70-75 (1984).
Touchstone, J. C. et al., "(3-sn-Phosphatidyl)cholines (Lecithins) in Amniotic Fluid", Clin. Chem., 29:1951-1954 (1983).
Weinberg, J. M. et al., "Alterations in Renal Cortex Cation Homeostasis During Mercuric Chloride and Gentamicin Nephrotoxicity", Exp. Mol. Pathol., 39:43-60 (1983).
Cortes, P. et al., "Effects of Early Diabetes on Uridine Diphosphosugar Synthesis in the Rat Renal Cortex", Kidney Int., 21:676-682 (1982).
Weibel, "Stereological Methods. Practical Methods for Biological Morphometry", (Academic Press, London) pp. 44-45 (1979) (article not provided) as applied by Hirose, K. et al., Development of Glomerular Lesions in Experimental Long-Term Diabetes in the Rat, Kidney Int., 21:689-695 (1982).
Radin, N. S., "Preparative Isolation of Cerebrosides (Galactosyl and Glucosyl Ceramide)", J. Lipid Res., 17:290-293 (1976).
Keppler, D. et al., "Enzymic Determination of Uracil Nucleotides in Tissues", Anal. Biochem., 38:105-114 (1970).
Shayman, J. A. et al., "Is Diabet
Radin Norman S.
Shayman James A.
Henley III Raymond J.
The Regents of the University of Michigan
Waddell Frederick E.
LandOfFree
Treatment of diabetic nephropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diabetic nephropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diabetic nephropathy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2099004